CRAD001AUS190T - Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress®) Monotherapy Early After Liver Transplantation

Project: Research project

StatusActive
Effective start/end date5/2/1611/30/20

Funding

  • Novartis Pharmaceuticals Corporation (CRAD001AUS190T)